Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
Treatment
Recommendation Grading
Disclaimer
Overview
Title
Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
Authoring Organization
American Society of Clinical Oncology
Publication Month/Year
April 26, 2021
Last Updated Month/Year
July 12, 2023
Supplemental Implementation Tools
Document Type
Guideline
Country of Publication
US
Target Patient Population
Obese adults who will receive systemic antineoplastic therapies (chemotherapy, immunotherapy, or targeted therapy).
Target Provider Population
Medical oncologists, oncology nurses, nurse practitioners, physician assistants, oncology pharmacists, and patients with cancer.
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Management
Diseases/Conditions (MeSH)
D001835 - Body Weight
Keywords
obesity, overweight, weight based dosing, dosing
Source Citation
Griggs JJ, Bohlke K, Balaban EP, Dignam JJ, Hall ET, Harvey RD, Hecht DP, Klute KA, Morrison VA, Pini TM, Rosner GL, Runowicz CD, Shayne M, Sparreboom A, Turner S, Zarwan C, Lyman GH. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update. J Clin Oncol. 2021 Jun 20;39(18):2037-2048. doi: 10.1200/JCO.21.00471. Epub 2021 May 3. PMID: 33939491.